225 related articles for article (PubMed ID: 8663239)
1. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
Carlberg M; Dricu A; Blegen H; Wang M; Hjertman M; Zickert P; Höög A; Larsson O
J Biol Chem; 1996 Jul; 271(29):17453-62. PubMed ID: 8663239
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.
Dricu A; Wang M; Hjertman M; Malec M; Blegen H; Wejde J; Carlberg M; Larsson O
Glycobiology; 1997 Jul; 7(5):625-33. PubMed ID: 9254045
[TBL] [Abstract][Full Text] [Related]
3. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to increased expression of IGF-1 receptors in human fibroblasts.
Carlberg M; Larsson O
Exp Cell Res; 1996 Feb; 223(1):142-8. PubMed ID: 8635486
[TBL] [Abstract][Full Text] [Related]
5. Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
Dricu A; Kanter L; Wang M; Nilsson G; Hjertman M; Wejde J; Larsson O
Glycobiology; 1999 Jun; 9(6):571-9. PubMed ID: 10336989
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.
Girnita L; Wang M; Xie Y; Nilsson G; Dricu A; Wejde J; Larsson O
Anticancer Drug Des; 2000 Feb; 15(1):67-72. PubMed ID: 10888037
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways.
Siddals KW; Marshman E; Westwood M; Gibson JM
J Biol Chem; 2004 Sep; 279(37):38353-9. PubMed ID: 15247258
[TBL] [Abstract][Full Text] [Related]
8. Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.
Carlberg M; Hjertman M; Wejde J; Larsson O
Exp Cell Res; 1994 Jun; 212(2):359-66. PubMed ID: 8187830
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors.
Larsson O
Glycobiology; 1993 Oct; 3(5):475-9. PubMed ID: 8286860
[TBL] [Abstract][Full Text] [Related]
10. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
Correll CC; Edwards PA
J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
[TBL] [Abstract][Full Text] [Related]
11. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells.
Martínez-González J; Viñals M; Vidal F; Llorente-Cortés V; Badimon L
Atherosclerosis; 1997 Dec; 135(2):213-23. PubMed ID: 9430371
[TBL] [Abstract][Full Text] [Related]
12. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
13. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme.
Nakanishi M; Goldstein JL; Brown MS
J Biol Chem; 1988 Jun; 263(18):8929-37. PubMed ID: 3379053
[TBL] [Abstract][Full Text] [Related]
14. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
15. Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40.
Larsson O; Barrios C; Latham C; Ruiz J; Zetterberg A; Zickert P; Wejde J
Cancer Res; 1989 Oct; 49(20):5605-10. PubMed ID: 2551491
[TBL] [Abstract][Full Text] [Related]
16. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
[TBL] [Abstract][Full Text] [Related]
17. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
[TBL] [Abstract][Full Text] [Related]
18. Effect of virus-transformation and growth factor stimulation on isoprene biosynthesis in human fibroblasts: a correlation to cell growth.
Larsson O
Cancer Biochem Biophys; 1995 Jan; 14(4):243-56. PubMed ID: 7767898
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control.
Peffley DM
Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367
[TBL] [Abstract][Full Text] [Related]
20. Regulation of porcine granulosa cell 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin and insulin-like growth factor I: synergism with follicle-stimulating hormone or protein kinase A agonist.
Maitra A; LaVoie HA; Day RN; Garmey JC; Veldhuis JD
Endocrinology; 1995 Nov; 136(11):5111-7. PubMed ID: 7588248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
